Velaglucerase alfa is an intravenous enzyme replacement therapy for Gaucher disease.1 The mechanism of action of velaglucerase alfa is presented in Figure 1. For further information on velaglucerase alfa, please consult your local prescribing information.

Figure 1.
Mechanism of action of velaglucerase alfa1,3

C-ANPROM/INT//7568; Date of preparation: September 2020

 
icon

DISEASE MANAGEMENT

Imiglucerase

What is imiglucerase?

Imiglucerase is an intravenous enzyme replacement therapy for Gaucher disease.

Read more
icon

DISEASE MANAGEMENT

Taliglucerase alfa

What is taliglucerase alfa?

Taliglucerase alfa is an intravenous enzyme replacement therapy for Gaucher disease.

Read more
icon

DISEASE MANAGEMENT

Enzyme replacement therapy

What enzyme replacement therapies are available for Gaucher disease?

Three long-term enzyme replacement therapies are available for patients with Gaucher disease: imiglucerase, velaglucerase alfa and taliglucerase alfa.

Read more
icon

Register

Registration gives the benefit of site update emails and additional information on new education materials and events

Registration